Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in Adults.

Pharmacoecon Open · 2025 · PMC12037965 · PMID 40153194

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The SUREG model on study 301 shows that the treatment effect of daridorexant on ISI is highly significant both at 1 month and at the final (3-month) follow-up.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.